TerrAscend (TSNDF) Goodwill & Intangibles (2020 - 2026)
TerrAscend's (TSNDF) quarterly Goodwill & Intangibles came in at $212.2 million in Q1 2026, up 48.06% year-on-year from $143.3 million in Q1 2025, and up 59.29% on a QoQ basis from $133.2 million in Q4 2025.
TerrAscend (TSNDF) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Goodwill & Intangibles data on file, last reported at $212.2 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 48.06% year-over-year to $212.2 million in Q1 2026; TTM through Mar 2026 was $212.2 million, a 48.06% increase from a year earlier, with the FY2025 full-year figure at $133.2 million, up 1.13% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $212.2 million, up from $133.2 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for TSNDF reached as high as $521.6 million in Q2 2022 and fell as low as $11.1 million in Q2 2023.
- Historically, Goodwill & Intangibles has averaged $205.8 million across 5 years, with a median of $174.4 million in 2025.
- Across the five-year window, Goodwill & Intangibles sank 97.88% in 2023 and soared 1394.61% in 2024, its largest moves.
- Year by year, Goodwill & Intangibles stood at $173.1 million in 2022, then retreated by 10.42% to $155.0 million in 2023, then retreated by 15.06% to $131.7 million in 2024, then grew by 1.13% to $133.2 million in 2025, then surged by 59.29% to $212.2 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $212.2 million in Q1 2026, $133.2 million in Q4 2025, and $174.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212.16 Mn |
| Dec 31, 2025 | 133.19 Mn |
| Sep 30, 2025 | 174.40 Mn |
| Jun 30, 2025 | 204.85 Mn |
| Mar 31, 2025 | 143.29 Mn |
| Dec 31, 2024 | 131.70 Mn |
| Sep 30, 2024 | 270.66 Mn |
| Jun 30, 2024 | 165.54 Mn |
| Mar 31, 2024 | 167.09 Mn |
| Dec 31, 2023 | 155.05 Mn |
| Sep 30, 2023 | 188.37 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 178.47 Mn |
| Dec 31, 2022 | 173.09 Mn |
| Sep 30, 2022 | 349.78 Mn |
| Jun 30, 2022 | 521.65 Mn |
| Mar 31, 2022 | 317.89 Mn |
| Dec 31, 2021 | 115.10 Mn |
| Dec 31, 2020 | 72.80 Mn |